|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | The evolution of thalidomide and its IMiD derivatives as anticancer agents显示文摘 | Bartlett JB Dredge K Dalgleish AG | 2004 | Nat Rev Cancer2004，4，4： | 1 |
| 2 | The evolution of thalidomide and its IMiD derivatives as anticancer agents显示文摘 | BARTLETT JB DREDGE K DALGLEISH AG | 2004 | Nat Rev Cancer2004，4，4： | 1 |
| 3 | The evolution of thalidomide and its IMiD derivatives as anticancer agents显示文摘 | Bartlett JB Dredge K Dalgleish AG | 2004 | Nat Rev Cancer2004，4，： | 1 |
| 4 | Cystic follicular disease in Michigan Holstein-Friesian cattle:incidence,descriptive epidemiology,and economic impact显示文摘 | Bartlett PC Ngategize PK Kaneene JB ctal | | 0，，： | 1 |
| 5 | Comparative efficacy of nucleoside/nucleotide reverse transcriptase inhibitors in combination with efavirenz:results of a systematic overview显示文摘 | Bartlett JA Chen SS Quinn JB | 2007 | HIV Clin Trials2007，8，4： | 1 |
| 6 | Phase I study of an im- munomodulatory thalidomide analog, CC-4047, in relapsed or refractory multiple myeloma显示文摘 | Schey SA Fields P Bartlett JB | 2004 | J Clin Oncol2004，22，16： | 1 |
| 7 | The evolution of thalidomide and its IMiD derivatives as anticancer agents显示文摘 | Bartlett JB Dredge K Dalgeish AG | 2004 | Nat Rev Cancer2004，4，4： | 1 |
| 8 | Antiproliferative effects of CC-8062 and CC-8075 in pancreatic cancer cells显示文摘 | Mouratidis PX Colston KW Bartlett JB | 2009 | Pancreas2009，38，1： | 1 |
| 9 | Phase I Study of an Immunomodulatory Thalidomide Analog,CC-4047,in Relapsed or Refractory Multiple Myeloma显示文摘 | Schey SA Fields P Bartlett JB | 2004 | J Clin Oncol2004，，： | 1 |
| 10 | Recent clinical studies of the immunomodulatory drug(IMiD)lenalidomide显示文摘 | Bartlett JB Tozer A Stirling D | 2005 | Br J Cancer2005，93，6： | 1 |
| 11 | Phase I study of an immunomodulatory thalidomide analog, CC-4047, in relapsed or refractory multiple myeloma显示文摘 | Schey SA Fields P Bartlett JB | 2004 | J Clin Oncol2004，22，： | 1 |
| 12 | The evolution of thalidomide and its IMiD derivatives as anticancer agents显示文摘 | Bartlett JB Dredge K Dalgleish AG | 2004 | Nat Rev Cancer2004，4，4： | 1 |
| 13 | Phase I study of an immunomodulatory thalidomide analog,CC-4047,in relapsed or refractory multiple myeloma显示文摘 | SCHEY SA FIELDS P BARTLETT JB | 2004 | J Clin Oncol2004，22，16： | 1 |
| 14 | Cystic follicular disease in Michigan Holstein-Friesian cattle:incidence,descriptive epidemiology,and economic impact显示文摘 | Bartlett PC Ngategize PK Kaneene JB | | 0，，： | 1 |
| 15 | Thalido- mide-derived immunomodulatory drugs as therapeutic agents 显示文摘 | Galustian C Labarthe MC Bartlett JB Dalglcish AG | 2004 | Expert Opin Biot Ther2004，4，12： | 1 |
| 16 | Antiproliferative effects of CC-8062 and CC-8075 in pancreatic cancer cells 显示文摘 | Mouratidis PX Colston KW Bartlett JB | 2009 | Pancreas2009，38，1： | 1 |
| 17 | The evolution of thalidomide and its IMiD derivatives as anticancer agents显示文摘 | BARTLETT JB DREDGE K DALGLEISH AG | 2004 | Nat Rev Cancer2004，4，4： | 1 |
| 18 | The evolutionof thalidomide and its IMiD derivatives as anticancer agents显示文摘 | BARTLETT JB DREDGE K DALGLEISH AG | 2004 | Nat Rev Cancer2004，4，4： | 1 |
| 19 | Thalidomide-derived immunomodulatory drugs as therapeutic agents显示文摘 | GALUSTIAN C LABARTHE MC BARTLETT JB | 2004 | Expert Opin Biol Ther2004，4，12： | 1 |
| 20 | Phase Ⅰ study of an immunomodulatory thalidomide analog,CC-4047,in relapsed or refractory multiple myeloma显示文摘 | SCHEY SA FIELDS P BARTLETT JB | 2004 | J Clin Oncol2004，22，8： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员